| Financial Year |
March 31 2023 |
| Monetary Funds |
658,362,890.95 |
| Held-for-trading Financial Assets |
10,995,143.34 |
| Notes Receivable |
22,495,004.77 |
| Accounts Receivable |
452,842,020.34 |
| Advances to Suppliers |
69,254,860.21 |
| Other Receivables |
27,492,357.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,349,567,745.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
76,602,706.96 |
| Total Current Assets |
2,876,462,416.72 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
25,280,473.64 |
| Long-term Equity Investment |
-- |
| Investment Properties |
405,411,066.88 |
| Fixed Assetes |
2,687,942,508.99 |
| Under-construction Projects |
288,024,856.07 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
224,349,654.97 |
| R&D expenses |
-- |
| Goodwill |
18,331.78 |
| Long-Term Deferred and Prepaid Expenses |
64,905,625.29 |
| Deferred Income Tax Assets |
70,185,304.59 |
| Other Non-Current Assets |
127,000.00 |
| Sub-Total of Non-Current Assets |
3,770,286,571.72 |
| Total Assets |
6,646,748,988.44 |
| Short-Term Loans |
1,878,588,221.49 |
| Trading Financial liabilities |
530,179.24 |
| Notes Payable |
704,507,033.46 |
| Accounts Payable |
484,348,930.09 |
| Accounts Received In Advance |
15,369,575.48 |
| Employee Compensation Payable |
6,348,731.58 |
| Taxes Payable |
29,292,884.30 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
24,216,693.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
97,173,853.96 |
| Other Current Liabilities |
1,010,387.63 |
| Sub-Total of Current Liabilities |
3,259,290,378.31 |
| Long-term Loans |
765,765,419.07 |
| Bonds Payable |
180,741,531.22 |
| Long-Term Accounts Payable |
107,707,483.68 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,657,690.83 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,267,408,893.72 |
| Total Liabilities |
4,526,699,272.03 |
| Paid-In Capital(Or Share Stock) |
498,855,117.00 |
| Capital Surplus |
795,174,432.12 |
| Surplus Reserve |
64,758,855.54 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
739,182,450.35 |
| Minority Stockholder's Interest |
6,814,214.81 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,113,235,501.60 |
| Owner's Equity（Stockholder's Equity） |
2,120,049,716.41 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,646,748,988.44 |
